Cargando…

Efficacy of antidotes (midazolam, atropine and HI-6) on nerve agent induced molecular and neuropathological changes

BACKGROUND: Recent alleged attacks with nerve agent sarin on civilians in Syria indicate their potential threat to both civilian and military population. Acute nerve agent exposure can cause rapid death or leads to multiple and long term neurological effects. The biochemical changes that occur follo...

Descripción completa

Detalles Bibliográficos
Autores principales: RamaRao, Golime, Afley, Prachiti, Acharya, Jyothiranjan, Bhattacharya, Bijoy Krishna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984638/
https://www.ncbi.nlm.nih.gov/pubmed/24708580
http://dx.doi.org/10.1186/1471-2202-15-47
_version_ 1782311461248303104
author RamaRao, Golime
Afley, Prachiti
Acharya, Jyothiranjan
Bhattacharya, Bijoy Krishna
author_facet RamaRao, Golime
Afley, Prachiti
Acharya, Jyothiranjan
Bhattacharya, Bijoy Krishna
author_sort RamaRao, Golime
collection PubMed
description BACKGROUND: Recent alleged attacks with nerve agent sarin on civilians in Syria indicate their potential threat to both civilian and military population. Acute nerve agent exposure can cause rapid death or leads to multiple and long term neurological effects. The biochemical changes that occur following nerve agent exposure needs to be elucidated to understand the mechanisms behind their long term neurological effects and to design better therapeutic drugs to block their multiple neurotoxic effects. In the present study, we intend to study the efficacy of antidotes comprising of HI-6 (1-[[[4-(aminocarbonyl)-pyridinio]-methoxy]-methyl]-2-[(hydroxyimino) methyl] pyridinium dichloride), atropine and midazolam on soman induced neurodegeneration and the expression of c-Fos, Calpain, and Bax levels in discrete rat brain areas. RESULTS: Therapeutic regime consisting of HI-6 (50 mg/kg, i.m), atropine (10 mg/kg, i.m) and midazolam (5 mg/kg, i.m) protected animals against soman (2 × LD(50), s.c) lethality completely at 2 h and 80% at 24 h. HI-6 treatment reactivated soman inhibited plasma and RBC cholinesterase up to 40%. Fluoro-Jade B (FJ-B) staining of neurodegenerative neurons showed that soman induced significant necrotic neuronal cell death, which was reduced by this antidotal treatment. Soman increased the expression of neuronal proteins including c-Fos, Bax and Calpain levels in the hippocampus, cerebral cortex and cerebellum regions of the brain. This therapeutic regime also reduced the soman induced Bax, Calpain expression levels to near control levels in the different brain regions studied, except a mild induction of c-Fos expression in the hippocampus. CONCLUSION: Rats that received antidotal treatment after soman exposure were protected from mortality and showed reduction in the soman induced expression of c-Fos, Bax and Calpain and necrosis. Results highlight the need for timely administration of better antidotes than standard therapy in order to prevent the molecular and biochemical changes and subsequent long term neurological effects induced by nerve agents.
format Online
Article
Text
id pubmed-3984638
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39846382014-04-14 Efficacy of antidotes (midazolam, atropine and HI-6) on nerve agent induced molecular and neuropathological changes RamaRao, Golime Afley, Prachiti Acharya, Jyothiranjan Bhattacharya, Bijoy Krishna BMC Neurosci Research Article BACKGROUND: Recent alleged attacks with nerve agent sarin on civilians in Syria indicate their potential threat to both civilian and military population. Acute nerve agent exposure can cause rapid death or leads to multiple and long term neurological effects. The biochemical changes that occur following nerve agent exposure needs to be elucidated to understand the mechanisms behind their long term neurological effects and to design better therapeutic drugs to block their multiple neurotoxic effects. In the present study, we intend to study the efficacy of antidotes comprising of HI-6 (1-[[[4-(aminocarbonyl)-pyridinio]-methoxy]-methyl]-2-[(hydroxyimino) methyl] pyridinium dichloride), atropine and midazolam on soman induced neurodegeneration and the expression of c-Fos, Calpain, and Bax levels in discrete rat brain areas. RESULTS: Therapeutic regime consisting of HI-6 (50 mg/kg, i.m), atropine (10 mg/kg, i.m) and midazolam (5 mg/kg, i.m) protected animals against soman (2 × LD(50), s.c) lethality completely at 2 h and 80% at 24 h. HI-6 treatment reactivated soman inhibited plasma and RBC cholinesterase up to 40%. Fluoro-Jade B (FJ-B) staining of neurodegenerative neurons showed that soman induced significant necrotic neuronal cell death, which was reduced by this antidotal treatment. Soman increased the expression of neuronal proteins including c-Fos, Bax and Calpain levels in the hippocampus, cerebral cortex and cerebellum regions of the brain. This therapeutic regime also reduced the soman induced Bax, Calpain expression levels to near control levels in the different brain regions studied, except a mild induction of c-Fos expression in the hippocampus. CONCLUSION: Rats that received antidotal treatment after soman exposure were protected from mortality and showed reduction in the soman induced expression of c-Fos, Bax and Calpain and necrosis. Results highlight the need for timely administration of better antidotes than standard therapy in order to prevent the molecular and biochemical changes and subsequent long term neurological effects induced by nerve agents. BioMed Central 2014-04-04 /pmc/articles/PMC3984638/ /pubmed/24708580 http://dx.doi.org/10.1186/1471-2202-15-47 Text en Copyright © 2014 RamaRao et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
RamaRao, Golime
Afley, Prachiti
Acharya, Jyothiranjan
Bhattacharya, Bijoy Krishna
Efficacy of antidotes (midazolam, atropine and HI-6) on nerve agent induced molecular and neuropathological changes
title Efficacy of antidotes (midazolam, atropine and HI-6) on nerve agent induced molecular and neuropathological changes
title_full Efficacy of antidotes (midazolam, atropine and HI-6) on nerve agent induced molecular and neuropathological changes
title_fullStr Efficacy of antidotes (midazolam, atropine and HI-6) on nerve agent induced molecular and neuropathological changes
title_full_unstemmed Efficacy of antidotes (midazolam, atropine and HI-6) on nerve agent induced molecular and neuropathological changes
title_short Efficacy of antidotes (midazolam, atropine and HI-6) on nerve agent induced molecular and neuropathological changes
title_sort efficacy of antidotes (midazolam, atropine and hi-6) on nerve agent induced molecular and neuropathological changes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984638/
https://www.ncbi.nlm.nih.gov/pubmed/24708580
http://dx.doi.org/10.1186/1471-2202-15-47
work_keys_str_mv AT ramaraogolime efficacyofantidotesmidazolamatropineandhi6onnerveagentinducedmolecularandneuropathologicalchanges
AT afleyprachiti efficacyofantidotesmidazolamatropineandhi6onnerveagentinducedmolecularandneuropathologicalchanges
AT acharyajyothiranjan efficacyofantidotesmidazolamatropineandhi6onnerveagentinducedmolecularandneuropathologicalchanges
AT bhattacharyabijoykrishna efficacyofantidotesmidazolamatropineandhi6onnerveagentinducedmolecularandneuropathologicalchanges